BSE Healthcare News and Updates

Name: Latest research reports of Zydus Lifesciences Ltd. authored by Deven Choksey and published by - Trendlyne research reports.
Item: Zydus Lifesciences Ltd.
Rating: 5
Author: Deven Choksey

Keep track of all breaking news on BSE Healthcare from all sources in a single place.

Load latest

Sun Pharmaceutical Industries Ltd.

26 Aug 2025

1578.70

0.86%

Sun Pharma shares slip 3% after BofA downgrade on premium valuations

Economic Times

Bank of America downgraded Sun Pharma stock to underperform' from neutral', citing risks to premium valuations and slower speciality execution. The brokerage cut its target price, flagging concerns over Ilumya's Medicare exposure, pricing pressures, and limited earnings visibility despite strong initial performance.

Sun Pharmaceutical I.. has an average target of 2050.25 from 8 brokers.

Senores Pharmaceuticals Ltd.

25 Aug 2025

712.70

2.33%

Broker's call: Senores Pharma (Buy)

Business Line

Choice International

Senores Pharmaceuticals Ltd. has gained 37.55% in the last 3 Months

Akums Drugs & Pharmaceuticals Ltd.

25 Aug 2025

474.05

0.29%

Akums Drugs announces JV to set up manufacturing facility in Zambia

Business Standard

Akums will hold 51% in its joint venture with the Zambian government to set up a pharma manufacturing facility, marking its first overseas plant and Africa expansion

Akums Drugs & Pharma.. has an average target of 655.00 from 1 broker.

Sai Life Science Ltd.

25 Aug 2025

847.85

2.72%

Cohance Lifesciences and other pharma stocks jump up to 5% after Jefferies initiates Buy recommendation

Economic Times

Cohance Lifesciences, Divi's Laboratories, and SAI Life Sciences rallied after Jefferies initiated coverage with Buy' ratings, citing strong growth prospects in India's CRDMO sector. The brokerage sees a high-teen revenue CAGR, led by China+1 diversification, pipeline visibility, and demand for diabetes and weight-loss therapies.

Sai Life Science Ltd. is trading above its 150 day SMA of 752.0

Narayana Hrudayalaya Ltd.

25 Aug 2025

1809.20

2.43%

Key highway projects to boost Mangaluru connectivity by mid-2026

Business Line

While works are underway on various stretches, road widening works on NH-169 will significantly reduce travel time between Mangaluru and tourist centres like Moodbidri and Karkala

Number of FII/FPI investors increased from 277 to 335 in Jun 2025 qtr.

Zydus Lifesciences Ltd.

25 Aug 2025

1008.20

1.21%

Q1FY26 performance stood stable amid slower traction in US offset by new product launches

Buy: Zydus Lifesciences Ltd.

Target

Deven Choksey

We have revised our FY26E/FY27E EPS estimates by +2.6%/-7.4% as we bake in slower revenue growth as Revlimid and Mirabegron sales is expected to taper-off and factor in a marginal increase in EBITDA margins in FY26, while we factor in weaker margins on the back of changing product mix towards competitive generics over FY27.

Zydus Lifesciences L.. has an average target of 1021.00 from 6 brokers.

Apollo Hospitals Enterprise Ltd.

24 Aug 2025

7736.00

0.70%

Hospital sector positioned for double-digit growth; Apollo Hospitals, Max Healthcare top picks

Economic Times

India's hospital sector shows strong momentum, with double-digit revenue and EBITDA growth supported by demand, bed expansions, and operational efficiencies. Despite margin pressures from new hospitals and slightly lower occupancy, capacity additions and rising healthcare demand position Apollo Hospitals and Max Healthcare for sustained profitability and attractive medium-term growth.

Promoters unpledged 0.36% of shares in last quarter. Total pledge stands at 13.11% of promoter holdings

Max Healthcare Institute Ltd.

24 Aug 2025

1162.00

0.02%

Hospitals To Suspend Cashless Services For Bajaj Allianz Policyholders From Sept. 1

NDTV Profit

This development is crucial as over 15,000 member hospitals including Max Healthcare and Medanta, which would now stop cashless treatment by Bajaj Allianz.

Max Healthcare Insti.. has an average target of 1268.57 from 7 brokers.

Krishna Institute of Medical Sciences Ltd.

23 Aug 2025

737.60

0.09%

Krishna Institute of Medical Sciences Targets 25-30% Revenue Growth Over Next Four Years

NDTV Profit

KIMS' growing reputation is attracting a higher volume of complex medical cases, which naturally leads to an increase in Average Revenue Per Occupied Bed (ARPOB), according to Dr Bhaskar Rao.

Number of FII/FPI investors increased from 226 to 257 in Jun 2025 qtr.

Narayana Hrudayalaya Ltd.

22 Aug 2025

1809.20

2.43%

Narayana Health unveils AIRA by Athma, AI tool for patient data management

Business Standard

Narayana Health's Athma incubator introduces AIRA, an AI-driven tool designed to streamline patient records, enhance efficiency, and reduce errors in healthcare.

Narayana Hrudayalaya Ltd. is trading below its 30 day SMA of 1851.3

Is BSE Healthcare worth buying?

20 Votes:

Buy 85.0%

Sell 10.0%

Hold 5.0%

BSE Healthcare PB	6.6
BSE Healthcare PE	39.9
BSE Healthcare DIV	0.5
BSE Healthcare EPS	1,109.3

Near 52W High of ₹46018.05

BSE Healthcare PB

BSE Healthcare PE

BSE Healthcare DIV

BSE Healthcare EPS

BSE Healthcare News and Updates

Keep track of all breaking news on BSE Healthcare from all sources in a single place.